Compare DOLE & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOLE | STAA |
|---|---|---|
| Founded | 1851 | 1982 |
| Country | Ireland | United States |
| Employees | N/A | 957 |
| Industry | Farming/Seeds/Milling | Ophthalmic Goods |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2021 | 1995 |
| Metric | DOLE | STAA |
|---|---|---|
| Price | $14.11 | $28.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $15.00 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.1M | 933.8K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.33 | 0.10 |
| Revenue | ★ $9,172,907,000.00 | $239,442,000.00 |
| Revenue This Year | $4.93 | $30.82 |
| Revenue Next Year | $1.72 | $8.41 |
| P/E Ratio | ★ $43.42 | $293.30 |
| Revenue Growth | ★ 8.23 | N/A |
| 52 Week Low | $12.52 | $15.59 |
| 52 Week High | $16.51 | $35.87 |
| Indicator | DOLE | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 46.70 | 48.42 |
| Support Level | $13.80 | $28.03 |
| Resistance Level | $14.37 | $33.86 |
| Average True Range (ATR) | 0.34 | 1.22 |
| MACD | 0.02 | -0.43 |
| Stochastic Oscillator | 48.68 | 15.61 |
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace. Geographically, the company operates in United States, Ireland, U.K. Spain, Sweden, and Others.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.